Puma Biotechnology reported $140.02M in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 1064.23M 241.05M
Cerulean Pharma CERU:US $ 55.3M 7.05M
Daiichi Sankyo 4568:JP Y 1310643M 40462M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Novartis NOVN:VX 45.72B 19.46B
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Spectrum Pharmaceuticals SPPI:US $ 93.18M 10.77M
Tg Therapeutics TGTX:US $ 330.96M 40.81M